Join Hawk Bio. at CPHI Frankfurt 2025

We are thrilled to announce our participation in CPHI Frankfurt 2025 – the world’s premier pharmaceutical networking event. We warmly invite you to visit us at Booth 11.0H62 to connect and explore partnership opportunities.

About Hawk Bio.

Founded in 1989, Hawk Bio. has dedicated over three decades to the production of Diosmin and Hesperidin APIs. With an annual capacity of over 1,000 tons, our products have been exported to more than 10 countries across Europe, the Americas, and Southeast Asia for 30+ years, earning deep trust and praise from global clients. We adhere to our core motto: Live by quality, thrive on prestige.

Our Strengths

• R&D Excellence: Home to an in-house R&D center and a team of experienced pharmaceutical experts, we hold dozens of national invention and utility model patents. We also serve as a reviewer for the international commercial standard of Hesperidin.
• Strict Quality Assurance: Equipped with a comprehensive GMP quality management system and a professional QA/QC team, we hold Drug Production License, completed CDE API registration, obtained CEP certificate (issued by EDQM) and ND (issued by Russian Ministry of Health), and finished Anvisa registration (Brazil). We have also passed ISO9001, Kosher, and Halal certifications.

We look forward to welcoming you at Booth 11.0H62 in Frankfurt, where we can address your needs and discuss potential collaborations.

See you at CPHI Frankfurt 2025!